You've been automatically redirected here from Humanzyme.com, which is now part of Proteintech Group. Click here to dismiss this alert.
  • HEK293 expressed
  • Endotoxin-free
  • Animal-component free

HumanKine® recombinant human IL-28A protein

Activity

Typically ≤ 5 ng/mL EC50

Species Reactivity

human

Purity

>95%

Cat no : HZ-1235

Synonyms

Cytokine Zcyto20, IFN lambda 2, IFNL2, IL 28A, IL28, IL-28, IL28A, IL-28A, Interferon lambda 2, Interleukin 28A, ZCYTO20



Technical Specifications

GeneID 282616
Species human
Expression HEK293
Activity Typically ≤ 5 ng/mL EC50
Purity >95%
Molecular Mass 24 kDa, monomer, non-glycosylated
Formulation 1x PBS, See Certificate of Analysis for details
Species Reactivity human

Stability and Reconstitution

Stability and Storage Lyophilized proteins are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.
Reconstitution Briefly centrifuge the vial before opening. It is recommended to reconstitute the protein in sterile 1xPBS containing 0.1% endotoxin-free recombinant human serum albumin (HSA).

Background

IL28A is a type III IFN, which shares many of the biological effects of type I IFNs but may have fewer side effects due to a more selective receptor distribution. It interacts with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). IL28A is believed to play a significant role in the antiviral immune defense in the intestinal epithelium (PMID: 20712453;12469119;16539846).

Synonyms

Cytokine Zcyto20, IFN lambda 2, IFNL2, IL 28A, IL28, IL-28, IL28A, IL-28A, Interferon lambda 2, Interleukin 28A, ZCYTO20

Publications

SpeciesTitle
human

J Virol Methods

Screening of novel drugs for inhibiting hepatitis E virus replication.

Authors - Takashi Nishiyama

Antiviral Res

Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.

Authors - Takashi Nishiyama